心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

慢性心力衰竭心脏康复中国专家共识

2020-12-12 中国康复医学会 中华内科杂志.2020.59(12):942-952.

慢性心力衰竭

研究证据表明，以运动为核心的心脏康复对慢性心力衰竭具有众多益处，目前均被国内外各大指南推荐，在国内临床实践中得到了积极推动。鉴于近年来国内外心力衰竭心脏康复在理念及方法方面均取得了最新研究进展，中国康

中文标题：

慢性心力衰竭心脏康复中国专家共识

发布机构：

中国康复医学会

发布日期：

2020-12-12

简要介绍：

研究证据表明，以运动为核心的心脏康复对慢性心力衰竭具有众多益处，目前均被国内外各大指南推荐，在国内临床实践中得到了积极推动。鉴于近年来国内外心力衰竭心脏康复在理念及方法方面均取得了最新研究进展，中国康复医学会心血管病预防与康复专业委员会组织相关领域专家撰写本共识，以期进一步推动我国慢性心力衰竭心脏康复的发展。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=慢性心力衰竭心脏康复中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9dfa01c002035e68, title=慢性心力衰竭心脏康复中国专家共识, enTitle=, guiderFrom=中华内科杂志.2020.59(12):942-952., authorId=0, author=, summary=研究证据表明，以运动为核心的心脏康复对慢性心力衰竭具有众多益处，目前均被国内外各大指南推荐，在国内临床实践中得到了积极推动。鉴于近年来国内外心力衰竭心脏康复在理念及方法方面均取得了最新研究进展，中国康, cover=https://img.medsci.cn/202115/1609852776834_2020535.jpg, journalId=0, articlesId=null, associationId=189, associationName=中国康复医学会, associationIntro=中国康复医学会是于1983年经卫生部批准成立并在民政部依法登记的全国性学术组织，1987年中国康复医学会加入中国科协，2001年加入国际物理医学与康复医学学会。, copyright=0, guiderPublishedTime=Sat Dec 12 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>研究证据表明，以运动为核心的心脏康复对慢性心力衰竭具有众多益处，目前均被国内外各大指南推荐，在国内临床实践中得到了积极推动。鉴于近年来国内外心力衰竭心脏康复在理念及方法方面均取得了最新研究进展，中国康复医学会心血管病预防与康复专业委员会组织相关领域专家撰写本共识，以期进一步推动我国慢性心力衰竭心脏康复的发展。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10036, tagName=慢性心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10036, guiderKeyword=慢性心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18155, appHits=1052, showAppHits=0, pcHits=1278, showPcHits=17100, likes=7, shares=127, comments=44, approvalStatus=1, publishedTime=Tue Jan 05 22:17:48 CST 2021, publishedTimeString=2020-12-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 05 21:20:07 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 11:58:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性心力衰竭心脏康复中国专家共识.pdf)])
慢性心力衰竭心脏康复中国专家共识.pdf
下载请点击：
评论区 (33)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078920, encodeId=fb7010e8920d9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sat Dec 11 00:09:52 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072738, encodeId=695f10e2738a7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Mon Nov 22 10:06:38 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069356, encodeId=72a410693568b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48725685256, createdName=杉杉子, createdTime=Thu Nov 11 20:10:29 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065748, encodeId=bc6d1065e485f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa4c5530185, createdName=黄小见, createdTime=Mon Nov 01 11:15:47 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051736, encodeId=35d71051e36ab, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:07:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-12-11 ms7000001100972409

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078920, encodeId=fb7010e8920d9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sat Dec 11 00:09:52 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072738, encodeId=695f10e2738a7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Mon Nov 22 10:06:38 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069356, encodeId=72a410693568b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48725685256, createdName=杉杉子, createdTime=Thu Nov 11 20:10:29 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065748, encodeId=bc6d1065e485f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa4c5530185, createdName=黄小见, createdTime=Mon Nov 01 11:15:47 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051736, encodeId=35d71051e36ab, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:07:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-11-22 1e1366a1m07(暂无匿称)

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1078920, encodeId=fb7010e8920d9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sat Dec 11 00:09:52 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072738, encodeId=695f10e2738a7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Mon Nov 22 10:06:38 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069356, encodeId=72a410693568b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48725685256, createdName=杉杉子, createdTime=Thu Nov 11 20:10:29 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065748, encodeId=bc6d1065e485f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa4c5530185, createdName=黄小见, createdTime=Mon Nov 01 11:15:47 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051736, encodeId=35d71051e36ab, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:07:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-11-11 杉杉子

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1078920, encodeId=fb7010e8920d9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sat Dec 11 00:09:52 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072738, encodeId=695f10e2738a7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Mon Nov 22 10:06:38 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069356, encodeId=72a410693568b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48725685256, createdName=杉杉子, createdTime=Thu Nov 11 20:10:29 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065748, encodeId=bc6d1065e485f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa4c5530185, createdName=黄小见, createdTime=Mon Nov 01 11:15:47 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051736, encodeId=35d71051e36ab, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:07:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-11-01 黄小见

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1078920, encodeId=fb7010e8920d9, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sat Dec 11 00:09:52 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072738, encodeId=695f10e2738a7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Mon Nov 22 10:06:38 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069356, encodeId=72a410693568b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48725685256, createdName=杉杉子, createdTime=Thu Nov 11 20:10:29 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065748, encodeId=bc6d1065e485f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa4c5530185, createdName=黄小见, createdTime=Mon Nov 01 11:15:47 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051736, encodeId=35d71051e36ab, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:07:36 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    值得学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

慢性心力衰竭基层诊疗指南（实践版·2019）

中华医学会(CMA,Chinese Medical Association) · 2019-10-30

慢性心力衰竭基层诊疗指南（2019年）

中华医学会(CMA,Chinese Medical Association) · 2019-10-30

2016 AHA科学声明：先天性心脏病患者的慢性心力衰竭

美国心脏协会(AHA,American Heart Association) · 2016-01-19

2016 SIGN国家临床指南：慢性心力衰竭的管理（147）

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2016-03-01

2016 慢性心力衰竭中西医结合诊疗专家共识

中国中西医结合学会(CAIM,Chinese Association of Integrative Medicine) · 2016-02-29

拓展阅读

2016 慢性心力衰竭中西医结合诊疗专家共识

中国中西医结合学会(CAIM,Chinese Association of Integrative Medicine) · 2016-02-29

2016 SIGN国家临床指南：慢性心力衰竭的管理（147）

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2016-03-01

2016 AHA科学声明：先天性心脏病患者的慢性心力衰竭

美国心脏协会(AHA,American Heart Association) · 2016-01-19

慢性心力衰竭基层诊疗指南（2019年）

中华医学会(CMA,Chinese Medical Association) · 2019-10-30

慢性心力衰竭基层诊疗指南（实践版·2019）

中华医学会(CMA,Chinese Medical Association) · 2019-10-30

慢性心力衰竭基层合理用药指南

中华医学会(CMA,Chinese Medical Association) · 2021-01-30